A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intravenous FDY 5301 in Patients With an Anterior ST-Elevation Myocardial Infarction

Trial Information
Status: Not yet recruiting
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Phase 3
Summary

To assess the effect of FDY-5301 on cardiovascular mortality and acute heart failure events in subjects with an anterior STEMI undergoing pPCI.

Am I eligible for this trial?
Who do I contact about this trial?
When is this trial taking place?
How many participants will be in this trial?
What treatment is being studied in this trial?
What other conditions are being studied in this trial?

This content was sourced from clinicaltrials.gov